dimyristoylphosphatidylcholine has been researched along with Neoplasm Metastasis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arima, C; Cao, K; Fujii, S; Fukui, T; Hasegawa, Y; Igarashi, Y; Inokuchi, J; Iwaki, S; Kato, S; Komizu, Y; Kyogashima, M; Matsumoto, Y; Mizutani, N; Mizutani, Y; Murate, T; Nakamura, M; Satou, A; Shiraishi, T; Suzuki, M; Tai, MC; Takahashi, T; Tamiya-Koizumi, K; Tanaka, K; Taniguchi, T; Togawa, N; Ueoka, R; Usami, N; Wakahara, K; Yanagisawa, K; Yokoi, K | 1 |
1 other study(ies) available for dimyristoylphosphatidylcholine and Neoplasm Metastasis
| Article | Year |
|---|---|
Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells.
Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Ceramides; Dimyristoylphosphatidylcholine; Humans; Lung Neoplasms; Male; Membrane Proteins; Mice; MicroRNAs; Neoplasm Metastasis; Phenotype; Sphingosine N-Acyltransferase | 2016 |